ResMed Inc. vs TORM plc — how do they compare? ResMed Inc. trades at $197.45 (market cap $28.81B), while TORM plc trades at $29.89 (market cap $2.99B). The key difference: ResMed Inc. is far larger — about 9.6× TORM plc's market cap, and TORM plc pays the higher dividend (9.62%). Which is the better fit depends on your goals.
| RMD | TRMD | |
|---|---|---|
Market Cap | $28.81B | $2.99B |
Sector | Health | Technology |
52-Week High | $293.73 | $34.87 |
52-Week Low | $182.82 | $17.50 |
Enterprise Value | $27.99B | $3.88B |
Dividend Yield | 1.21% | 9.62% |
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →